U.S. Markets open in 3 hrs 52 mins
S&P Futures
4,136.25+8.50(+0.21%)Dow Futures
33,757.00+48.00(+0.14%)Nasdaq Futures
13,774.25+24.00(+0.17%)
BioLineRx Ltd. (BLRX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8300+0.0500 (+1.80%)
At close: 4:00PM EDT
2.8500 +0.02 (0.71%)
Pre-Market: 4:37AM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 2.7800 |
| Open | 2.9800 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 900 |
| Day's Range | 2.7501 - 3.0400 |
| 52 Week Range | 1.4000 - 4.2300 |
| Volume | 1,320,475 |
| Avg. Volume | 2,022,096 |
| Market Cap | 117.213M |
| Beta (5Y Monthly) | 1.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7850 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.33 |
- PR Newswire
BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today announced that the Company has presented a poster at the AACR Annual Meeting, which is being held April 10-15 on a virtual basis."
- ACCESSWIRE
BioLineRx Ltd. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 23, 2021 / BioLineRx Ltd. (NASDAQ:BLRX) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 23, 2021 at 10:00 AM Eastern Time.
- PR Newswire
BioLineRx Reports Year-End 2020 Financial Results and Provides Corporate Update
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the year ended December 31, 2020 and provides a corporate update.
© 2021 Verizon Media. All rights reserved.
